An Introduction to Paediatric Endocrinology
Paediatric endocrinology is a complex field incorporating many conditions such as over or under activity of the pituitary, thyroid and adrenal glands, type 1 diabetes and metabolic bone disease that affect the paediatric population. Collaboration between a multidisciplinary team of paediatric endocrinology specialists, adult endocrinologists and specialist nurses is important to ensure coordinated and comprehensive care.
Browse our gallery of video highlights and short articles from the conference hub, providing the latest expert insights from major conferences and peer-reviewed articles from the journal portfolio.
Paediatric Endocrinology Content
Get Excited for ESPE 2020!
ESPE European Society for Paediatric Endocrinology Hear from those who are helping shape the ESPE 2020 experience! Find out more at: www.eurospe.org/meetings/2020/espe2020/ and see why you need to attend this year’s Meeting in Liverpool from the 10 – 12 September 2020.
Efficacy and Safety Evaluation of Human Growth Hormone Therapy in Patients with Idiopathic Short Stature in Korea – A Randomised Controlled Trial
European Endocrinology. 2020;16(1):54-9
Growth hormone (GH) is approved in children to treat growth failure in several indications including GH deficiency, Turner syndrome and short children born small for gestational age,1 and is approved in the USA but not in Europe for the treatment of idiopathic short stature (ISS).2 ISS describes short children with normal GH secretion, with height >2 standard […]
TransCon Growth Hormone in the Treatment of Paediatric Growth Hormone Deficiency – Results of the Phase III heiGHt Trial
Paediatric growth hormone deficiency (GHD) is an orphan disease characterised by abnormally short stature, increased and abnormal fat distribution and metabolic abnormalities, and can be congenital or acquired. In GHD, the pituitary gland does not produce sufficient growth hormone, which is important not only for height but also for optimal bone, heart, muscle and brain […]
A New Paediatric Diabetes Knowledge Test – M-WIKAD Development and Factor Analysis
European Endocrinology. 2019;15(1):Epub ahead of print DOI: https://doi.org/10.17925/EE.2019.15.1.1
The purpose of this study was to develop a measure of type 1 diabetes mellitus (T1DM) knowledge that is aimed at youth and is based on contemporary management standards. The Mercy What I Know About Diabetes (M-WIKAD) is a 19-item questionnaire that is a valid measure of diabetes knowledge in youth with T1DM. Factor […]
Thomas Danne, EASD 2018 – latest advances in paediatric diabetes
Professor Danne explores recent developments in paediatric diabetes. Questions: 1. What are the latest advances in paediatric diabetes care? (0:12) 2. What are the current developments in new insulins, glucose sensors and insulin pumps? (0:50) 3. What are your highlights of EASD 2018 so far, and which presentations or data are you most interested in? […]
Male Central Hypogonadism in Paediatrics – the Relevance of Follicle-stimulating Hormone and Sertoli Cell Markers
European Endocrinology, 2018;14(2):67–71 DOI: https://doi.org/10.17925/EE.2018.14.2.67
In the adult male, hypogonadism is usually defined by the failure of the testis to produce physiological concentrations of testosterone and/or a normal number of spermatozoa.1 When due to abnormalities of the hypothalamic-pituitary axis, the condition is referred to as hypogonadotropic or central hypogonadism, whereas those due to testicular defects are called hypergonadotropic or primary […]
Key Developments in Pediatric Endocrinology in 2015
US Endocrinology, 2016;12(2):87–9 DOI: https://doi.org/10.17925/USE.2016.12.02.87
Growth/growth hormone/insulin-like growth factors Evidence has long supported insulin-like growth factor-2 (IGF-2) as an important fetal growth factor. Begemann and co-workers from Germany and the Netherlands report four patients from a multigenerational family with the combination of severe intrauterine and postnatal growth retardation, relative macrocephaly, and Russell–Silver syndrome-like features, found to be caused by a […]
Diabetes Technology and Therapy in the Pediatric Age Group
US Endocrinology 2016;12(1):22–3 DOI: http://doi.org/10.17925/USE.2016.12.01.22
Recent developments in diabetes technology—CSII, AP and CGM We are currently in an extremely exciting time for diabetes technology which holds near-term promise to substantially improve the lives of children with type 1 diabetes (T1D). Recent data published by the Type 1 Diabetes Exchange confirms what clinical experience has shown for years, that diabetes control […]
Neonatal Screening for Congenital Hypothyroidism with Focus on Developing an Indian Screening Programme
European Endocrinology, 2016;12(2):99–103 DOI: http://doi.org/10.17925/EE.2016.12.02.99
The human foetus is capable of producing thyroid hormones at around 20 weeks of gestation. Even in the rare event that there happens to be a defect in thyroid organogenesis or an inborn error in thyroid hormone synthesis, the developing foetal brain is protected by the trans-placental supply of maternal T4. Within the cerebral cortex […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!